Vanberra Signal

ScreenPoint

Curated by Signal

Provider of AI-based medical image analysis systems

Overview

Provider of AI-based medical image analysis systems. The company's flagship product, Transpara is based on the automated analysis of digital mammograms and breast tomosynthesis data for the early detection of breast cancer. Transpara enables decision support for soft tissue lesions, CAD, and exam selection for pre-screening.

Key facts

Founded
2014

Business model

Contact

Open roles

7 roles
  • Information Security Officer

    Nijmegen, Gelderland, Netherlands · On-site · Volunteer

  • Software Engineer

    Nijmegen, Gelderland, Netherlands · On-site · Volunteer

  • Postdoc – AI Foundation Models for Breast Cancer Recurrence

    Copenhagen Municipality, Capital Region of Denmark, Denmark · On-site · Volunteer

+ 4 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a device used for the detection of strabismus

    Life Sciences TechnologyNetherlands
  • Developer of noninvasive device that detects and treats sleep apnea

    Life Sciences TechnologyAmsterdam, Netherlands

About ScreenPoint

What does ScreenPoint do?

Provider of AI-based medical image analysis systems.

Where is ScreenPoint headquartered?

ScreenPoint is headquartered in Nijmegen, Netherlands.

When was ScreenPoint founded?

ScreenPoint was founded in 2014.

Which sector is ScreenPoint in?

ScreenPoint operates in Life Sciences Technology.

Who are ScreenPoint's competitors?

Companies similar to ScreenPoint include XEye medical, Pasithea, and Deena Bioinformatics.

Is ScreenPoint hiring?

Yes. ScreenPoint has 7 open roles listed on Vanberra Signal.